ea0056gp95 | Diabetes Therapy | ECE2018
Dominguez-Lopez Marta Elena
, Vallejo Rosario
, Morillas Virginia
, Colomo Natalia
, Guerrero Mercedes
, Rojo Gema
, de Adana Navas Marisol Ruiz
Background: There arent published randomized studies comparing the clinical impact of degludec and Glragina U300 in the treatment of type 1 diabetes patients. (T1DP)Objective: To compare efficacy and safety of the new long acting analogues Glargine U 300 and Degludec in 300 Type1 diabetes patients treated with basal/bolus treatment.(BBT)Material and methods: Randomized control study 1.1 in 300 T1DP treated with BBT with glarg...